The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1α, IL-6, GM-CSF, and KC

Clinical and Experimental Metastasis

Volumn 16, Issue 7, 1998, Pages 655-664

  Smith, Conrad W ^a   Chen, Zhong ^a   Dong, Gang ^a   Loukinova, Elena ^a   Pegram, Michelle Y ^a   Nicholas Figueroa, Linda ^a   Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

IL 1 ; IL 6; IL 8 and GM CSF; Proinflammatory cytokines; Squamous cell carcinoma

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6;

ANIMAL CELL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL TRANSFORMATION; CELLULAR IMMUNITY; ENVIRONMENTAL FACTOR; GROWTH REGULATION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; KERATINOCYTE; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES; CHEMOKINES, CXC; CLONING, ORGANISM; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MICE, INBRED BALB C;

EID: 0032425625     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006559811429     Document Type: Article

References (40)

1. 1. Sato K, Fujii Y, Kakiuchi T, et al., 1989, Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing parathyroid hormone-related protein, interleukin 1, and granulocyte colony-stimulating factor. Cancer Res, 49, 4740-6.
2. 2. Mann E, Spiro J, Chen L and Kreutzer D, 1992, Cytokine expression by head and neck squamous cell carcinoma. American J Surgery, 164, 567-73.
3. 3. Pak A, Wright M, Matthews J, et al., 1995, Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34+ cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor 1. Clin Cancer Res, 1, 95-103.
4. 4. Cohen R, Contrino J, Spiro J, et al., 1995, Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 121, 202-9.
5. 5. Woodworth C, McMullin E, Iglesias M and Plowman G, 1995, Interleukin 1 α and tumor necrosis factor α stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci (USA), 92, 2840-4.
6. 6. Fried R, Voelkel E, Rice R, et al., 1989, Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1. Endocrinology, 125, 742-51.
7. 7. Nowak R, Morrison N, Goad D, et al., 1990, Squamous cell carcinomas often produce more than a single bone resorption-stimulating factor: role of interleukin-1. Endocrinology, 127, 3061-9.
8. 8. Lahm H, Wyniger J, Hertig S, et al., 1994, Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res, 54, 3700-2.
9. 9. Monti S, Szymczuk S, Motta MR, et al., 1993, GM-CSF production in human adenocarcinoma lines. J Biol Regul Homeost Agents, 7, 85-91.
10. 10. Pekarek LA, Weichselbaum RR, Beckett MA, et al., 1993, Footprinting of individual tumors and their variants by constitutive cytokine expression patterns. Cancer Res, 53, 1978-81.
11. 11. Singh RK, Gulman M, Radinsky R, et al., 1994, Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res, 54, 3242-7.
12. 12. Yamamura M, Modlin R, Ohmen J and Moy R, 1993, Local expression of antiinflammatory cytokines in cancer. J Clin Invest, 91, 1005-10.
13. 13. Stevenson FT, Turck J, Locksley RM and Lovett DH, 1997, The N-terminal propiece of interleukin 1 α is a transforming nuclear oncoprotein. Proc Natl Acad Sci, 94, 508-13.
14. 14. Hilbert DH, Kopf M, Mock BA, et al., 1995, Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med, 182, 243-8.
15. 15. Smith D, Polverini P, Kunkel S, et al., 1994, Inhibition of intereukin 8 attenuates angiogenesis in brochogenic carcinoma. J Exp Med, 179, 1409-15.
16. 16. Arenberg D, Kunkel S, Polverini P, et al., 1996, Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest, 97, 2792-802.
17. 17. Balentien E, Mufson BE, Shattuck RL, et al., 1991, Effects of MGSA/GRO alpha on melanocyte transformation. Oncogene, 6, 1115-24.
18. 18. Giavazzi R, Garofalo A, Bani MR, et al. 1990, Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res, 50, 4771-5.
19. 19. Chirivi RG, Garofalo A, Padura IM, et al., 1993, Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res, 53, 5051-4.
20. 20. Vidal-Vanaclocha F, Amezaga C, Asumedi A, et al., 1994, Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res, 54, 2667-72.
21. 21. Anasagasti MJ, Olaso E, Calvo F, et al., 1997, Interleukin 1-dependent and -independent mouse melanoma metastases. J Natl Cancer Inst, 89, 9.
22. 22. Reichner JS, Mulligan JA, Palla ME, et al., 1996, Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity. Arch Surg, 131, 360-2.
23. 23. Gutman M, Singh RK, Xie K, et al., 1995, Regulation of interleukin-8 expression in human melanoma cells by the organ enviroment. Cancer Res, 55, 2470-5.
24. 24. Milas L, Faykus MH, Jr, McBride WH, et al., 1984, Concomitant development of granulocytosis and enhancement of metastases formation in tumor-bearing mice. Clin Exp Metastasis, 2, 181-90.
25. 25. Nicoletti G, Lollini PL, Bagnara GP, et al., 1987, Are colony stimulating factor-producing cells facilitated in the metastatic process? Anticancer Res, 7, 695-700.
26. 26. Tsuchiya Y, Igarashi M, Suzuki R, and Kumagai K, 1988, Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol, 141, 699-708.
27. 27. Takeda K, Hatakeyama K, Tsuchiya Y, et al., 1991, A correlation between GM-CSF expression and metastases in murine tumors. Int J Cancer, 47, 413-20.
28. 28. Young MRI and Wright MA, 1992, Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: γ interferon plus tumor necrosis factor a synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis. Cancer Res, 52, 6335-40.
29. 29. Chen Z, Smith CW, Kiel D and Van Waes C, 1997, Metastastic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin Exp Metastasis, 15, 527-37.
30. 30. Dong G, Loukinova E, Smith CW, et al., 1997, Identification of genes that are differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma. J Cell Biochem, S28/29, 90-100.
31. 31. Yuspa SH, Hawley-Nelson P, Koehler B and Stanley JR, 1980, A survey of transformation markers in differentiating epidermal cell lines. Cancer Res, 40, 4694-703.
32. 32. Lefkovits I and Waldmann H, 1979, Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press.
33. 33. Wolf G, Hudson J, Peterson K, et al., 1986, Lymphocyte subpoplulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head & Neck Surgery, 95, 142-52.
34. 34. Snyderman C, Heo D, Chen K, et al., 1989, T-Cell markers in tumor-infiltrating lymphocytes of head and neck cancer. Head & Neck, 11, 331-6.
35. 35. Wolf G, Chretien P and Elias E, 1979, Serum glycoproteins in head and neck squamous cell carcinoma: Correlations with tumor extent clinical tumor stage and T-cell levels during chemotherapy. Am J Surg, 128, 489-500.
36. 36. Veltri R, Rodman S, Maxim P, et al., 1986, Immune complexes, serum protein, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck. Cancer, 57, 2295-308.
37. 37. Yoneda T, Aufdemorte T, Nishimura R, et al., 1991, Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: A novel experimental model of three concomitant paraneoplastic syndromes. J Clin Oncol, 9, 468-77.
38. 38. Young M and Newby M. 1986, Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants. J Natl Cancer Inst, 77, 1255-60.
39. 39. Seung L, Seung S and Schreiber H, 1995, Antigenic cancer cells that escape immune destruction are stimulated by host cells. Cancer Res, 55, 5094-100.
40. 40. Pekarek L, Starr B, Toledano A and Schreiber H, 1995, Inhibition of tumor growth by elimination of granulocytes. J Exp Med, 181, 435-40.